Child Psychiatry Consult

Anxiety disorders: Psychopharmacologic treatment update


 

Summary

Pharmacotherapy for anxiety disorders often includes the advice that, if medications are indicated in conjunction with psychotherapy, to start with an SSRI; and if that is not effective to try a different one.7 An SNRI such as venlafaxine or duloxetine may then be a third-line alternative, although for youth with comorbid ADHD, consideration of either atomoxetine or guanfacine is also reasonable. Beyond that point, there unfortunately are little systematic data to guide pharmacologic decision making, and increased potential risks of other classes of medications suggest the need for caution and consultation.

Dr. David C. Rettew is a child and adolescent psychiatrist and associate professor of psychiatry and pediatrics at the University of Vermont, Burlington.

Dr. David C. Rettew

Dr. Rettew is a child and adolescent psychiatrist and associate professor of psychiatry and pediatrics at the University of Vermont, Burlington. Follow him on Twitter @PediPsych.

Looking for more mental health training? Attend the 12th annual Child Psychiatry in Primary Care conference in Burlington, on May 4, 2018,organized by the University of Vermont with Dr. Rettew as course director. Go to http://www.med.uvm.edu/cme/conferences.

References

1. Merikangas KR et al. J Am Acad Child Adolesc Psychiatry. 2010 Oct;49(10):980-9.

2. Strawn JR et al. Depress Anxiety. 2015 Mar;32(3):149-57.

3. Walkup J et al. N Engl J Med. 2008 Dec 25;359(26):2753-66.

4. Batelaan N et al. BMJ. 2017 Sep 13;358:j3927.

5. Strawn JR et al. J Child Adolesc Psychopharm. 2017 Feb;27(1): 29-37..

6. Geller D et al. J Am Acad Child Adolesc Psychiatry. 2007 Sep;46(9):1119-27.

7. Strawn JR et al. J Child Adolesc Psychopharm. 2017 Feb;28(1): 2-9.

Next Article: